1. AHRO : Austin Health Research Online

Thomas John

View Statistics Email Alert RSS Feed
 Claim profile

Profile

Credit Name
Thomas John
Full Name
John, Thomas
 
Variants
John, Tom
 
Department
 
Personal Site
https://www.onjcancercentre.org/profile/a-prof.-tom-john
 
Loading... 2 0 20 0 false
Loading... 3 0 20 0 false
ORCID

Publications

Refined By:
Author:  Lu, Shun
Date Issued:  2022

Results 1-4 of 4 (Search time: 0.003 seconds).

Publication YearTitleAuthor(s)
11-Jun-2022Health-Related Quality of Life Outcomes in Patients with Resected Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer Who Received Adjuvant Osimertinib in the Phase III ADAURA Trial.Majem, Margarita; Goldman, Jonathan W; John, Thomas ; Grohe, Christian; Laktionov, Konstantin; Kim, Sang-We; Kato, Terufumi; Vu, Huu Vinh; Lu, Shun; Li, Shanqing; Lee, Kye Young; Akewanlop, Charuwan; Yu, Chong-Jen; de Marinis, Filippo; Bonanno, Laura; Domine, Manuel; Shepherd, Frances A; Atagi, Shinji; Zeng, Lingmin; Kulkarni, Dakshayini; Medic, Nenad; Tsuboi, Masahiro; Herbst, Roy S; Wu, Yi-Long
229-Apr-2022Long-Term Efficacy and Safety of Entrectinib in ROS1 Fusion-Positive NSCLC.Drilon, Alexander; Chiu, Chao-Hua; Fan, Yun; Cho, Byoung Chul; Lu, Shun; Ahn, Myung-Ju; Krebs, Matthew G; Liu, Stephen V; John, Thomas ; Otterson, Gregory A; Tan, Daniel S W; Patil, Tejas; Dziadziuszko, Rafal; Massarelli, Erminia; Seto, Takashi; Doebele, Robert C; Pitcher, Bethany; Kurtsikidze, Nino; Heinzmann, Sebastian; Siena, Salvatore
3Apr-2022First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in advanced non-small cell lung cancer: a subanalysis of Asian patients in CheckMate 9LA.John, Thomas ; Sakai, Hiroshi; Ikeda, Satoshi; Cheng, Ying; Kasahara, Kazuo; Sato, Yuki; Nakahara, Yoshiro; Takeda, Masayuki; Kaneda, Hiroyasu; Zhang, Helong; Maemondo, Makoto; Minato, Koichi; Hisada, Takeshi; Misumi, Yuki; Satouchi, Miyako; Hotta, Katsuyuki; Li, Ang; Oukessou, Abderrahim; Lu, Shun
42022Postoperative Chemotherapy Use and Outcomes From ADAURA: Osimertinib as Adjuvant Therapy for Resected EGFR-Mutated NSCLC.Wu, Yi-Long; John, Thomas ; Grohe, Christian; Majem, Margarita; Goldman, Jonathan W; Kim, Sang-We; Kato, Terufumi; Laktionov, Konstantin; Vu, Huu Vinh; Wang, Zhijie; Lu, Shun; Lee, Kye Young; Akewanlop, Charuwan; Yu, Chong-Jen; de Marinis, Filippo; Bonanno, Laura; Domine, Manuel; Shepherd, Frances A; Zeng, Lingmin; Atasoy, Ajlan; Herbst, Roy S; Tsuboi, Masahiro